Metagenomi Therapeutics Inc
MGX
Closed
$1.20
Closed
-(-)
At close
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply
About
The company is headquartered in Emeryville, California and currently employs 119 full-time employees. The company went IPO on 2024-02-09.
Key stats
Open
$1.22
Volume
303.20K
Market cap
$46.47M
Prev. close
$1.23
Impl / hst vl
-
Open interest
$0.00
$1.20
Day’s Range
$1.26
$1.13
52W Range
$1.86
Valuation
22
Valuation score
Overvalued
P/E
-
P/S
2.08
P/B
0.34
Current ratio
-
Debt / Equity
-
ROE
-
Gross margin
-
Income growth
-
FCF growth
-7.37
Analysts estimates
Consensus rating
Buy
The average rating from top 5 analysts indicates that stock is expected to perform in line with the market
Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$7.82
The top 4 analysts forecasts that 12-month price may increase by 551.67%, with a low of $5.05 and a high of $9.45
$5.05
Low
$7.82
Avg
$9.45
High
Current price
Earnings
Q1 ‘26 revenue
$1.25M
Q1 ‘26 net income
-$23.06M
Revenue
Net income
Previous EPS
-$0.61
Estimate EPS
-$0.58
Actual EPS
Estimate EPS
Explore the Healthcare sector
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply